Innonco Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Innonco General Information
Description
Developer of cancer drugs by targeting immunologic derangement designed to improve the life of cancer patients. The company is currently operating in stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
- United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
- United States
Innonco Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | Completed | Stealth | ||||
| 1. Early Stage VC | 01-Jan-2018 | Completed | Stealth |
Innonco FAQs
-
Where is Innonco headquartered?
Innonco is headquartered in .
-
What industry is Innonco in?
Innonco’s primary industry is Drug Discovery.
-
Is Innonco a private or public company?
Innonco is a Private company.
-
What is Innonco’s current revenue?
The current revenue for Innonco is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process